EXPLEOSOL

Expleo Solutions Share Price

₹1,244.60 -3.8 (-0.3%)

14 Jun, 2025 07:22

SIP TrendupStart SIP in EXPLEOSOL

Start SIP

Performance

  • Low
  • ₹1,203
  • High
  • ₹1,259
  • 52 Week Low
  • ₹735
  • 52 Week High
  • ₹1,567
  • Open Price₹1,225
  • Previous Close₹1,248
  • Volume77,875

Investment Returns

  • Over 1 Month + 40.62%
  • Over 3 Month + 47.39%
  • Over 6 Month -13.17%
  • Over 1 Year -1.45%
SIP Lightning

Smart Investing Starts Here Start SIP with Expleo Solutions for Steady Growth!

Invest Now

Expleo Solutions Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18.7
  • PEG Ratio
  • 1.3
  • Market Cap Cr
  • 1,932
  • P/B Ratio
  • 2.9
  • Average True Range
  • 51.32
  • EPS
  • 66.52
  • Dividend Yield
  • 4
  • MACD Signal
  • 51.68
  • RSI
  • 81.91
  • MFI
  • 95.39

Expleo Solutions Financials

Expleo Solutions Technicals

EMA & SMA

Current Price
₹1,244.60
-3.8 (-0.3%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹1,058.44
  • 50 Day
  • ₹992.50
  • 100 Day
  • ₹1,018.80
  • 200 Day
  • ₹1,101.88

Resistance and Support

1235.63 Pivot Speed
  • R3 1,323.67
  • R2 1,291.33
  • R1 1,267.97
  • S1 1,212.27
  • S2 1,179.93
  • S3 1,156.57

What's your outlook on Expleo Solutions?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Expleo Solutions Ltd. provides technology consulting and quality assurance services, specializing in software testing, engineering, and digital transformation. Serving industries like banking, aerospace, and automotive, it delivers innovative solutions to improve business efficiency and performance globally.

Expleo Solutions has an operating revenue of Rs. 1,024.80 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 14% is healthy, ROE of 16% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 35% and 8% from 50DMA and 200DMA. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 75 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 159 indicates it belongs to a poor industry group of Computer-Tech Services and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Expleo Solutions Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-22 Audited Results
2025-02-06 Quarterly Results & Interim Dividend
2024-11-14 Quarterly Results
2024-08-01 Quarterly Results
2024-05-23 Audited Results
Date Purpose Remarks
2025-02-12 INTERIM Rs.50.00 per share(500%)Interim Dividend
2023-07-14 FINAL Rs.5.00 per share(50%)Dividend
View More

Expleo Solutions F&O

Expleo Solutions Shareholding Pattern

71.05%
0.33%
0%
22.02%
6.6%

About Expleo Solutions

  • NSE Symbol
  • EXPLEOSOL
  • BSE Symbol
  • 533121
  • Managing Director & CEO
  • Mr. Balaji Viswanathan
  • ISIN
  • INE201K01015

Similar Stocks to Expleo Solutions

Expleo Solutions FAQs

Expleo Solutions share price is ₹1,244 As on 14 June, 2025 | 07:08

The Market Cap of Expleo Solutions is ₹1931.6 Cr As on 14 June, 2025 | 07:08

The P/E ratio of Expleo Solutions is 18.7 As on 14 June, 2025 | 07:08

The PB ratio of Expleo Solutions is 2.9 As on 14 June, 2025 | 07:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23